Why This Doctor Invests In Tesla Weekly?
I met a doctor recently who has been buying up as much Tesla as he can get his hands on. Remarkably he told me that he buys shares of Tesla every single week, accumulating as big a position as he possibly can.
In light of Tesla shares falling this past week after Musk made some almost outlandish predictions – » Read more about: Why This Doctor Invests In Tesla Weekly? »
Read More200 Billion Reasons To Buy This Payment Processor
The Shift4 story begins like many tech legends – with founders working out of their parents’ basements. However, in addition to the fact that Shift4 isn’t based in Silicon Valley, there is a key difference between this company and its tech peers. Shift4 wasn’t founded by a college dropout. In fact, its founder didn’t go to college at all.
» Read more about: 200 Billion Reasons To Buy This Payment Processor »
Read More
1 Stock So Cheap It’s a STEAL?
Crocs started selling its trademark footwear in 2002, and it rapidly became an iconic American brand. Before long, the shoes gained a global following, and today, more than 720 million pairs have been sold in 90+ countries.
Originally, there was just one style — a soft, lightweight sandal made from Crocs’ proprietary Croslite material.
» Read more about: 1 Stock So Cheap It’s a STEAL? »
Read More
1 Buffett Stocks Near 52-Week Lows
On December 4, 2020, Verizon shares were trading for about $61.50. That’s the highest price Verizon has ever managed to reach. From that moment, the price took a turn for the worse. Over the last 52 weeks, Verizon has been as high as $59.85 and as low as $49.68.
Although the share price has underwhelmed recently,
» Read more about: 1 Buffett Stocks Near 52-Week Lows »
Read More
1 FinTech Firm with 30.6% Upside
When you study business for a while, certain metrics just turn out to be much more important than others. The cost to acquire customers is a key focus for many new business owners but their retention is what those who have been around the block focus on.
If you can acquire customers at the same price as the competition but sell them into many other products and services,
» Read more about: 1 FinTech Firm with 30.6% Upside »
Read MoreThe Burst
Massive Upside In Big Money Pharma Favorite?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes in the use of immune therapies for cancer treatment. Specifically, Iovance is exploring new applications of tumor infiltrating lymphocyte (TIL) therapy, utilizing cells that the human body naturally produces to attack cancerous tumors.
There was lots of hype about this next-generation cancer treatment company but its share price has been decidedly lackluster this year,
» Read more about: Massive Upside In Big Money Pharma Favorite? »
Read MoreThe Ivy
1 High-Yield Casino REIT That Keeps Raising Dividends
VICI Properties (NYSE:VICI) is a REIT that specializes in hotel and casino properties. Spun off from Caesar Entertainment in 2017, the company owns several of the most prominent properties in the United States.
Assets owned by VICI include Caesar’s Palace and The Venetian Resort in Las Vegas, Chelsea Piers in New York and the Hard Rock Casino in Cincinnati.
» Read more about: 1 High-Yield Casino REIT That Keeps Raising Dividends »
Read MoreThe Daily
Apple To Release iPhone 17 Early Next Year
According to Bloomberg, Apple (NASDAQ: AAPL) will release a number of new products in the first half of next year.
» Read more about: Apple To Release iPhone 17 Early Next Year »